Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study A companion observational study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
M
Martin Farlow, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to help researchers understand the changes in thinking and memory that may occur in older individuals by comparing individuals who do not have elevated amyloid levels in the brain to individuals who do have elevated ayloid.
Description
The purpose of this study is to help researchers understand the changes in thinking and memory that may occur in older individuals by comparing individuals who do not have elevated amyloid levels in the brain to individuals who do have elevated ayloid.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Alzheimer's disease
-
Age: - 100 Years
-
Gender: All
Updated on
26 Apr 2024.
Study ID: 1503087978
